SCHEMBL9490227

SCHEMBL9490227

COC[C@H]1CCCN1N=C1CCCCC1c1cccnc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.43
CHRNA7 P36544 4/20 0.43
CHRNA4 P43681 4/20 0.43
CHRNB4 P30926 4/20 0.43
CHRNA3 P32297 4/20 0.43
CHRNB1 P11230 3/20 0.43
CHRNB3 Q05901 3/20 0.43
CHRNA1 P02708 2/20 0.43
ALDH1A1 P00352 4/20 0.43
CHRNA2 Q15822 2/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTR3E A5X5Y0 1/20 0.39
PSIP1 O75475 1/20 0.39
TRPA1 O75762 1/20 0.39
HTR3B O95264 1/20 0.39
CHRNG P07510 1/20 0.39
MAPT P10636 1/20 0.39
CYP2A6 P11509 1/20 0.39
PTGS1 P23219 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9490122 1.00 CHRNB2 (0.43) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9492862 1.00 CHRNB2 (0.43) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9491388 1.00 CHRNB2 (0.43) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9655993 1.00 CHRNB2 (0.43) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9656446 0.79 CHRNB2 (0.41) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9656460 0.79 CHRNB2 (0.41) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9328846 0.79 CHRNB2 (0.41) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9328852 0.79 CHRNB2 (0.41) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL9656452 0.79 CHRNB2 (0.41) CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3
SCHEMBL31643342 0.71 KCNH2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246950-A Smooth muscle disorders RHONE-POULENC SANTE (FR) 1993-09-21 US disclosed